InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the full record of transactions filed by Andrade, Robert Christopher. Director active across 1 company, notably Fennec Pharmaceuticals INC.. Aggregated, 6 disclosures have been published. Split: 6 buys · 0 sell. Total volume traded: €919k. History available since 27 August 2026. The latest transaction was disclosed on 28 August 2026 (10 - Acquisition or disposition in the public market). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations